XML 24 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:      
Net income $ 2,237,700,000 $ 1,285,500,000 $ 349,400,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 998,400,000 1,143,500,000 1,153,300,000
Deferred income taxes 205,500,000 7,900,000 (138,900,000)
Share-based compensation expense related to equity incentive plans 170,400,000 210,200,000 198,300,000
Loss on settlement of debt 8,300,000 113,400,000 299,600,000
Amortization of debt discount 7,200,000 44,900,000 71,100,000
Amortization of debt issuance costs 9,500,000 11,500,000 17,100,000
Impairment of intangible assets 1,800,000 3,000,000.0 0
Other non-cash adjustment (1,800,000) (11,400,000) (6,400,000)
Changes in operating assets and liabilities, excluding impact of acquisitions:      
Increase in accounts receivable (232,700,000) (74,900,000) (63,700,000)
(Increase) decrease in inventories (483,200,000) (177,800,000) 18,400,000
Increase in accounts payable and accrued liabilities 323,400,000 192,700,000 17,600,000
Change in other assets and liabilities 404,500,000 79,400,000 (16,700,000)
Change in income tax payable (28,000,000.0) 14,800,000 17,400,000
Net cash provided by operating activities 3,621,000,000 2,842,700,000 1,916,500,000
Cash flows from investing activities:      
Proceeds from sales of assets 900,000 14,100,000 8,300,000
Investments in other assets (114,200,000) (121,700,000) (89,000,000.0)
Capital expenditures (486,200,000) (370,100,000) (92,600,000)
Net cash used in investing activities (599,500,000) (477,700,000) (173,300,000)
Cash flows from financing activities:      
Proceeds from issuance of senior notes 0 997,000,000.0 3,577,800,000
Repayment of senior notes 0 (1,000,000,000) 0
Repayment of Bridge Loan Facility 0 0 (615,000,000.0)
Payments on settlement of convertible debt (170,400,000) (424,700,000) (2,611,400,000)
Deferred financing costs 0 (8,500,000) (21,200,000)
Purchase of capped call options 0 0 (35,800,000)
Proceeds from sale of common stock 82,300,000 70,500,000 60,300,000
Tax payments related to shares withheld for vested RSUs (75,800,000) (84,200,000) (64,600,000)
Repurchase of common stock (945,800,000) (425,600,000) 0
Payment of cash dividends (695,300,000) (503,800,000) (388,300,000)
Capital lease payments (800,000) (800,000) (600,000)
Net cash used in financing activities (3,104,900,000) (2,327,600,000) (1,864,200,000)
Net (decrease) increase in cash and cash equivalents (83,400,000) 37,400,000 (121,000,000.0)
Cash and cash equivalents, and restricted cash at beginning of period 317,400,000 280,000,000.0 401,000,000.0
Cash and cash equivalents, and restricted cash at end of period 234,000,000.0 317,400,000 280,000,000.0
Revolving Credit Facility      
Cash flows from financing activities:      
Proceeds from borrowings on Revolving Credit Facility 5,935,000,000 4,176,000,000 3,966,000,000
Repayments of line of credit (7,234,100,000) (5,123,500,000) (4,007,900,000)
Term Loan Facility      
Cash flows from financing activities:      
Repayments of line of credit $ 0 $ 0 $ (1,723,500,000)